Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
UMS increases lithotripsy business
USMD Health Systems has sold US Lithotripsy LP to United Medical Systems, Inc. (UMS), a subsidiary of private investment firm New State Capital Partners. UMS provides turnkey mobile lithotripsy, laser and stereotactic breast biopsy services to patients at 850 healthcare facilities in the U.S., Canada and Latin America. The acquired company, US Lithotripsy, is a provider of lithotripsy services at facilities in Arizona, Arkansas, Colorado, Missouri, Oklahoma and Texas. It performs over 12,000 ESWL (Extracorporeal Shock Wave Lithotripsy) procedures annually. With its acquisition by UMS, US Lithotripsy will add more than 100 hospitals, ambulatory surgical centers and other sites of service in... Read More »Agenus on a roll in 2015
Agenus Inc., an immunology company developing novel checkpoint modulators, vaccines and adjuvants to treat cancer, acquired Phoslmmune Inc. last week. Phoslmmune is an immunotherapy company that has discovered a new portfolio of cancer neoantigens. Its equity holders will receive an upfront payment of $2.5 million in cash and $7.4 million in shares of Agenus common stock at closing, plus milestone payments of up to $35 million in cash and/or stock. This acquisition gives Agenus the capacity to expediate the development of new cancer vaccines and other single-agent immuno-oncology approaches, as well as combination therapies. And the deal most likely caps a healthy year for Agenus, which... Read More »Recent Health Care Deals, week ending 12.25.15
AcquirerTargetPrice eHealth naviHealthRightCare Solutions, Inc.N/A QPharma, Inc.Qforma, Inc.N/A Invoice Cloud, Inc.ImageVision.NetN/A ABILITY NetworkOCS HomeCare and Hospice analytics... Read More »Pharma’s Big Year in M&A
With one week to go in 2015, there are still a few big pharmaceutical deals in the works. Shire plc (NASDAQ: SHPG) is now in friendly talks to take over Baxalta International Inc. (NYSE: BXLT) for a price rumored to be above $30 billion. By who’s waiting for 2016? Here is a preliminary tally of the year in pharmaceutical M&A, and how it compares to previous years. Spoiler alert: 2015 is another record year in dollar value. Pharmaceutical M&A, 2011 to 2015* 20112012201320142015 Deal volume115103150188167 % change11%-10%46%25%-11% Deal value$44.1 billion$38.1 billion$66.7 billion$213.3 billion$297.4 billion % change11%-14%76%219%40% *= thru Dec.... Read More »Hospital M&A in 2015
It’s been a busy year for mergers and acquisitions in the Hospital sector, and it’s not over yet. Our preliminary figures show 101 transactions with a combined deal value of $8.7 billion. At least two announced transactions have been terminated, and there are still a few to track down, so those numbers will change. Of those 101 deals, 89 acquirers were other hospitals or health systems. One was a behavioral health company, Sovereign Health Group, which runs residential treatment centers for mental health and substance abuse patients through its affiliate, Ashland Properties LLC. Private equity firms made six acquisitions, and REITs made five. The largest of those REIT... Read More »Shryver Medical and Revelstoke Capital Double Down in Texas
Schryver Medical LLC, a portfolio company of Revelstoke Capital Partners, announced two acquisitions in Texas in late December. Community Portable X-Ray, Inc., as its name implies, provides mobile x-ray and other imaging services to long-term health care facilities, home care, psychiatric hospitals, industrial sites, dialysis centers and athletic teams. Besides its base in Plano, it also has operations in Fort Worth, Houston and San Antonio. The second acquisition is a combination of MetroStat Clinical Laboratory Inc. and MetroStat Diagnostic Services (collectively, MetroStat). MetroStat provides digital ultrasound and EKG teleradiology equipment that allow its technologists to obtain the... Read More »WellSpan Ups Its Behavioral Health Offerings
The Behavioral Health Care sector has seen plenty of mergers and acquisitions this year. Deal volume is currently up 38% (33 deals) compared with 2014’s full-year total of 24 transactions. With six deals announced in December, the sector will close out the year on a high note. One deal has been in the works almost all year, and will become effective on January 1, 2016. WellSpan Health, a five-hospital system based in York, Pennsylvania, and Philhaven, a mental and behavioral health agency of the Lancaster Conference of the Mennonite Church USA, finalized their affiliation plans on December 17. Philhaven provides services throughout Lancaster, Lebanon, Dauphin, and York counties. The... Read More »Recent Health Care Deals, week ending 12.18.15
AcquirerTargetPrice Gilead Sciences, Inc. Global partnership with Galapagos NV$725 million AstraZeneca plcAcerta Pharma B.V.$4 billion AEA Investors LP1-800-Contacts, Inc. N/A PharMerica CorporationAlternacare Infusion PharmacyN/A TeamHealth Holdings, Inc. Geriatric... Read More »Martin Shkreli, We Hardly Knew Ye
Actually, we know Martin Shkreli, CEO of KaloBios Pharmaceuticals (NASDAQ: KBIO), all too well. The brash young man was arrested by the Federal Bureau of Investigations yesterday in Manhattan, on charges of fraud relating to his days at a hedge. Just weeks before, as then-CEO of privately held Turing Pharmaceuticals, he became the poster child of drug price gougers, having boosted the price of a long-marketed generic drug by 5000%, from $13.50 per pill to $750. The revelations in a New York Times story brought swift recriminations from all sides, including presidential candidates. The most striking note for us, as health care database wonks, is that Shkreli launched his first biotech... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
